Similar Items: Development of aminoquinoline-benzimidazole hybrids and their organometallic complexes as antimicrobial agents against Plasmodium falciparum and Mycobacterium tuberculosis
- Expanding the versatility of aminoquinoline organometallic complexes as anticancer and antibacterial agents
- Synthesis, characterisation and pharmacological evaluation of silicon-containing aminoquinoline organometallic complexes as antiplasmodial, antitumor and antimycobacterial agents
- The synthesis and evaluation of new organometallic benzimidazole Complexes as antiplasmodials
- Haemozoin formation, effects of chloroquine on iron distribution in Plasmodium falciparum and the correlation of thermordynamic and structural factors with 4-aminoquinoline activity
- Synthesis and biological evaluation of trimeric 2,5-disubstituted benzimidazoles and related trinuclear ruthenium(II) organometallic complexes
- Development of organosilane-containing bioorganometallic compounds evaluated as antiparasitic agents against Plasmodium falciparum and Trichomonas vaginalis
Author: Smith, Gregory
- Design, synthesis and biological evaluation of bioorganometallic metallarectangles
- Expanding the versatility of aminoquinoline organometallic complexes as anticancer and antibacterial agents
- Synthesis and biological evaluation of trimeric 2,5-disubstituted benzimidazoles and related trinuclear ruthenium(II) organometallic complexes
- Antimalarial Evaluation of Quinoline-triazoleMn(I) and Re(I) PhotoCORMs
- Synthesis and biological evaluation of polynuclear cyclometalated ruthenium, rhodium and iridium complexes based on a PPI dendritic scaffold
- The development of group VIII trinuclear transition metal complexes as chemotherapeutic and photodynamic therapy agents
Author: Baartzes, Nadia
- Mono- and polynuclear Ferrocenyl-derived complexes: synthesis, characterisation and biological evaluation as antimycobacterial and antiplasmodial agents
- Development of aminoquinoline-benzimidazole hybrids and their organometallic complexes as antimicrobial agents against Plasmodium falciparum and Mycobacterium tuberculosis